ID   M4K1_HUMAN              Reviewed;         833 AA.
AC   Q92918;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   05-OCT-2010, entry version 97.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Hematopoietic progenitor kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 1;
DE            Short=MEK kinase kinase 1;
DE            Short=MEKKK 1;
GN   Name=MAP4K1; Synonyms=HPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH MAP3K1.
RC   TISSUE=Fetal liver;
RX   MEDLINE=96421968; PubMed=8824585;
RA   Hu M.C.-T., Qiu W.R., Wang X., Meyer C.F., Tan T.-H.;
RT   "Human HPK1, a novel human hematopoietic progenitor kinase that
RT   activates the JNK/SAPK kinase cascade.";
RL   Genes Dev. 10:2251-2264(1996).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366 AND SER-368, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-376; TYR-381;
RP   SER-407; SER-413; SER-421 AND SER-586, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-374; SER-376;
RP   SER-377; SER-421 AND SER-586, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; SER-407; SER-413
RP   AND SER-421, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-312; SER-351; LEU-361 AND PHE-737.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in the response to environmental stress.
CC       Appears to act upstream of the JUN N-terminal pathway. May play a
CC       role in hematopoietic lineage decisions and growth regulation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Interacts with MAP3K1.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=1; IntAct=EBI-881, EBI-375543;
CC       P46108:CRK; NbExp=2; IntAct=EBI-881, EBI-886;
CC       P46109:CRKL; NbExp=3; IntAct=EBI-881, EBI-910;
CC       P06241:FYN; NbExp=1; IntAct=EBI-881, EBI-515315;
CC       P62993:GRB2; NbExp=1; IntAct=EBI-881, EBI-401755;
CC       P16333:NCK1; NbExp=1; IntAct=EBI-881, EBI-389883;
CC       P27986:PIK3R1; NbExp=1; IntAct=EBI-881, EBI-79464;
CC       P19174:PLCG1; NbExp=5; IntAct=EBI-881, EBI-79387;
CC       P12931:SRC; NbExp=1; IntAct=EBI-881, EBI-621482;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in hematopoietic organs,
CC       including bone marrow, spleen and thymus. Also expressed at very
CC       low levels in lung, kidney, mammary glands and small intestine.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CNH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66464; AAB97983.1; -; mRNA.
DR   IPI; IPI00020258; -.
DR   RefSeq; NP_009112.1; -.
DR   UniGene; Hs.95424; -.
DR   ProteinModelPortal; Q92918; -.
DR   SMR; Q92918; 7-276.
DR   IntAct; Q92918; 29.
DR   MINT; MINT-1176198; -.
DR   STRING; Q92918; -.
DR   PhosphoSite; Q92918; -.
DR   PRIDE; Q92918; -.
DR   Ensembl; ENST00000221409; ENSP00000221409; ENSG00000104814.
DR   GeneID; 11184; -.
DR   UCSC; uc002oix.1; human.
DR   CTD; 11184; -.
DR   GeneCards; GC19M039078; -.
DR   H-InvDB; HIX0040128; -.
DR   HGNC; HGNC:6863; MAP4K1.
DR   HPA; CAB007754; -.
DR   HPA; HPA007419; -.
DR   MIM; 601983; gene.
DR   PharmGKB; PA30609; -.
DR   eggNOG; prNOG05567; -.
DR   HOGENOM; HBG315791; -.
DR   HOVERGEN; HBG036702; -.
DR   InParanoid; Q92918; -.
DR   OMA; SGPPPRT; -.
DR   PhylomeDB; Q92918; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; tcrjnkpathway; JNK signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; kitpathway; Signaling events mediated by Stem cell factor receptor (c-Kit).
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   NextBio; 42561; -.
DR   PMAP-CutDB; Q92918; -.
DR   ArrayExpress; Q92918; -.
DR   Bgee; Q92918; -.
DR   CleanEx; HS_MAP4K1; -.
DR   Genevestigator; Q92918; -.
DR   GermOnline; ENSG00000104814; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0005083; F:small GTPase regulator activity; IEA:InterPro.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0000185; P:activation of MAPKKK activity; IC:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR001180; Citron.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    833       Mitogen-activated protein kinase kinase
FT                                kinase kinase 1.
FT                                /FTId=PRO_0000086273.
FT   DOMAIN       17    274       Protein kinase.
FT   DOMAIN      495    800       CNH.
FT   NP_BIND      23     31       ATP (By similarity).
FT   ACT_SITE    137    137       Proton acceptor (By similarity).
FT   BINDING      46     46       ATP (By similarity).
FT   MOD_RES     324    324       Phosphoserine.
FT   MOD_RES     366    366       Phosphoserine.
FT   MOD_RES     368    368       Phosphoserine.
FT   MOD_RES     374    374       Phosphoserine.
FT   MOD_RES     376    376       Phosphoserine.
FT   MOD_RES     377    377       Phosphoserine.
FT   MOD_RES     381    381       Phosphotyrosine.
FT   MOD_RES     405    405       Phosphoserine.
FT   MOD_RES     407    407       Phosphoserine.
FT   MOD_RES     413    413       Phosphoserine.
FT   MOD_RES     421    421       Phosphoserine.
FT   MOD_RES     586    586       Phosphoserine.
FT   VARIANT     312    312       P -> T (in dbSNP:rs55924696).
FT                                /FTId=VAR_040739.
FT   VARIANT     351    351       P -> S (in dbSNP:rs34591617).
FT                                /FTId=VAR_040740.
FT   VARIANT     361    361       P -> L (in dbSNP:rs56060067).
FT                                /FTId=VAR_040741.
FT   VARIANT     737    737       S -> F (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040742.
FT   VARIANT     811    811       N -> S (in dbSNP:rs12975825).
FT                                /FTId=VAR_051643.
SQ   SEQUENCE   833 AA;  91296 MW;  3C98CF01BE42E151 CRC64;
     MDVVDPDIFN RDPRDHYDLL QRLGGGTYGE VFKARDKVSG DLVALKMVKM EPDDDVSTLQ
     KEILILKTCR HANIVAYHGS YLWLQKLWIC MEFCGAGSLQ DIYQVTGSLS ELQISYVCRE
     VLQGLAYLHS QKKIHRDIKG ANILINDAGE VRLADFGISA QIGATLARRL SFIGTPYWMA
     PEVAAVALKG GYNELCDIWS LGITAIELAE LQPPLFDVHP LRVLFLMTKS GYQPPRLKEK
     GKWSAAFHNF IKVTLTKSPK KRPSATKMLS HQLVSQPGLN RGLILDLLDK LKNPGKGPSI
     GDIEDEEPEL PPAIPRRIRS THRSSSLGIP DADCCRRHME FRKLRGMETR PPANTARLQP
     PRDLRSSSPR KQLSESSDDD YDDVDIPTPA EDTPPPLPPK PKFRSPSDEG PGSMGDDGQL
     SPGVLVRCAS GPPPNSPRPG PPPSTSSPHL TAHSEPSLWN PPSRELDKPP LLPPKKEKMK
     RKGCALLVKL FNGCPLRIHS TAAWTHPSTK DQHLLLGAEE GIFILNRNDQ EATLEMLFPS
     RTTWVYSINN VLMSLSGKTP HLYSHSILGL LERKETRAGN PIAHISPHRL LARKNMVSTK
     IQDTKGCRAC CVAEGASSGG PFLCGALETS VVLLQWYQPM NKFLLVRQVL FPLPTPLSVF
     ALLTGPGSEL PAVCIGVSPG RPGKSVLFHT VRFGALSCWL GEMSTEHRGP VQVTQVEEDM
     VMVLMDGSVK LVTPEGSPVR GLRTPEIPMT EAVEAVAMVG GQLQAFWKHG VQVWALGSDQ
     LLQELRDPTL TFRLLGSPRL ECSGTISPHC NLLLPGSSNS PASASRVAGI TGL
//
